ENDVHealthcareNano-Cap
ENDONOVO THERAPEUTICS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for ENDONOVO THERAPEUTICS, INC. (ENDV), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are ENDV insiders buying or selling?
ENDONOVO THERAPEUTICS, INC. insiders reported 132 open-market buys ($132.7K) and 0 sells ($0) across 132 Form 4 filings — a net buying position of $132.7K.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 7, 2020)
Total Form 4 filings
132
SEC EDGAR
Insider filers
2
Insider buys (132)
$132.7K
Insider sells (0)
$0
Insider sentiment
Net buyingNet insider flow of $132.7K in net buying.
Recent ENDV insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 7, 2020 | Alan Brian Collier | CEO | Purchase | 400 | $0.10 | $40.98 |
| Feb 26, 2020 | Alan Brian Collier | Director | Purchase | 100 | $0.96 | $96.49 |
| Jan 24, 2020 | Alan Brian Collier | CEO | Purchase | 200 | $2.00 | $400 |
| Jan 24, 2020 | Alan Brian Collier | CEO | Purchase | 5.7K | $0.03 | $163.24 |
| Jan 24, 2020 | Alan Brian Collier | Ceo | Purchase | 200 | $2.00 | $400 |
| Jan 1, 2020 | Alan Brian Collier | Ceo | Purchase | 5.7K | $0.00 | $13.39 |
| Dec 9, 2019 | Alan Brian Collier | Ceo | Purchase | 15.0K | $0.00 | $46.3 |
| Nov 26, 2019 | Alan Brian Collier | Ceo | Purchase | 3.0K | $0.00 | $11.3 |
| Nov 15, 2019 | Alan Brian Collier | Ceo | Purchase | 2.0K | $0.01 | $14.2 |
| Nov 4, 2019 | Alan Brian Collier | CEO | Purchase | 51.2K | $0.01 | $269.45 |
| Oct 15, 2019 | Alan Brian Collier | CEO | Purchase | 10.4K | $0.01 | $106.96 |
| Oct 3, 2019 | Alan Brian Collier | CEO | Purchase | 600 | $0.01 | $5.5 |
| Sep 27, 2019 | Alan Brian Collier | CEO | Purchase | 700 | $0.01 | $4.57 |
| Sep 16, 2019 | Alan Brian Collier | CEO | Purchase | 32.0K | $0.01 | $288.2 |
| Sep 6, 2019 | Alan Brian Collier | CEO | Purchase | 114.0K | $0.01 | $1.1K |
| Aug 30, 2019 | Alan Brian Collier | CEO | Purchase | 119.0K | $0.01 | $1.2K |
| Aug 23, 2019 | Alan Brian Collier | CEO | Purchase | 55.0K | $0.01 | $597 |
| Aug 16, 2019 | Alan Brian Collier | CEO | Purchase | 89.5K | $0.01 | $917.6 |
| Aug 9, 2019 | Alan Brian Collier | CEO | Purchase | 62.0K | $0.01 | $698.4 |
| Jul 25, 2019 | Alan Brian Collier | CEO | Purchase | 96.0K | $0.01 | $1.2K |
| Jul 16, 2019 | Alan Brian Collier | CEO | Purchase | 59.7K | $0.02 | $921.34 |
| Jul 10, 2019 | Alan Brian Collier | CEO | Purchase | 275.0K | $0.02 | $4.4K |
| Jun 28, 2019 | Alan Brian Collier | CEO | Purchase | 75.0K | $0.02 | $1.2K |
| Jun 18, 2019 | Alan Brian Collier | CEO | Purchase | 52.0K | $0.01 | $635.5 |
| Jun 11, 2019 | Alan Brian Collier | CEO | Purchase | 111.0K | $0.01 | $1.3K |
Showing the 25 most recent of 132 Form 4 filings for ENDONOVO THERAPEUTICS, INC..
Most active ENDV insiders
- Michael Scott Mann70 filings
- Alan Brian Collier62 filings
Ask anything about ENDV insider activity
Use Trabud's AI agent to query ENDONOVO THERAPEUTICS, INC.'s Form 4 history in plain English — "Show me ENDV CEO purchases this year" or compare it against any other ticker.
Open the AI agentENDV insider trading FAQ
Are ENDONOVO THERAPEUTICS, INC. insiders buying or selling?
Across 132 SEC Form 4 filings, ENDONOVO THERAPEUTICS, INC. (ENDV) insiders reported 132 open-market purchases totaling $132.7K and 0 sales totaling $0. That is a net buying position of $132.7K.
How many insiders trade ENDV stock?
2 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for ENDONOVO THERAPEUTICS, INC.. The most recent filing was accepted on Jul 7, 2020.
Where does Trabud get ENDV insider trading data?
All ENDV insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.